Europe’s leading digital social commerce company for nutritional supplements and beauty products, LR Health & Beauty, has released its financial results for Q2 and H1 2025. While revenue saw a modest decline, the company’s profitability metrics tell a different story, one of resilience and strategic financial management.
In Q2 2025, LR Health & Beauty generated €68.9 million in sales, a 2.6% decline from the same period last year (Q2 2024: €70.7 million). For the first half of 2025, revenue totaled €142.9 million, down 0.3% from H1 2024 (€143.3 million).
Yet, despite the revenue softness, LR Health & Beauty delivered a standout performance in profitability. Reported EBITDA surged 13.6% year-over-year to €13.3 million in H1 2025 (H1 2024: €11.7 million).
The company noted that refinancing costs tied to a previous bond redemption had weighed on earnings in the prior-year period. Normalized EBITDA also climbed 6.3% to €15.3 million (H1 2024: €14.4 million), underscoring operational efficiency gains.
New leadership team
As of 1 August 2025, Mr Jörg Körfer was appointed Chief Executive Officer (CEO). He brings extensive expertise in global direct sales from his many years of senior management positions at internationally operating companies, including Bofrost and Vorwerk.
In addition, LR has strengthened its management team with the appointment of Mr Ante Franicevic, who serves as Interim Chief Financial Officer (CFO). Mr Franicevic contributes more than 20 years of senior management experience in finance at well-known retail and consumer brands such as Douglas, Jack Wolfskin and Metro.
